ClinicalTrials.gg
Status unknownNCT02772913Updated May 5, 2017

Mesenteric Ischemia in the Emergency Department: a Retrospective Multicenter Study

An observational study in Acute Mesenteric Ischemia, sponsored by University of Genova. Status unknown at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-05-05.

Sponsored by University of Genova · Observational

The sponsor has not verified this record recently (last verified May 2017), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
500
Ages
18 Years and older
Sex
All
01

Study summary

Acute mesenteric ischemia is a life-threatening condition characterized by high mortality if unrecognized early. This multicenter retrospective observational study will review the emergency departments's (ED) notes of all patients discharged from hospital with a diagnosis of acute mesenteric ischemia in 2014-2015 comparing it with those admitted to the ED for abdominal pain in the same timeframe.

Read the detailed description

Acute mesenteric ischemia is a condition characterized by non-specific presentation (typical clinical presentation is considered "abdominal pain out of proportion to examination") that may be under-recognized in the Emergency Department. Early identification and treatment is essential to improve outcome as mortality rate is attested around 80% if untreated within few hours from onset. The investigators aim to review the emergency department's clinical notes of patients discharged from hospital in 2014 and 2015 diagnosed with acute mesenteric ischemia. Furthermore the investigators will consider patients admitted for "abdominal pain" in the same time frame without acute mesenteric ischemia and we will compare presentation symptoms, medical history, medications, vitals, laboratory markers and imaging finding of the two groups. From this comparison, the investigators will be able to clarify the incidence among general population and among patients presenting acute abdominal pain. Finally, using multivariate analysis, the investigators may identify those variables predictive of acute mesenteric ischemia. This study will be held in three university hospitals and all data analyzed together.

02

Conditions studied

  • Acute Mesenteric Ischemia

Browse trials for

03

In context

Mesenteric Ischemia

40 studies on the registry are indexed under Mesenteric Ischemia; 14 are open to participants now.

This study's planned enrollment of 500 is above the median of 154 across 26 observational studies indexed under Mesenteric Ischemia.

Browse Mesenteric Ischemia studies →

Lead sponsor

University of Genova is the lead sponsor of 34 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients discharged from hospital with ICD-9 code related to acute mesenteric ischemia (1st cohort) compared with patients admitted for acute abdominal pain

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ICD-9 diagnosis of acute mesenteric ischemia in 2014 and 2015
  • Admitted to hospital after Emergency Department assessment
  • age>18

Exclusion criteria

Exclusion Criteria:

  • age\<18
  • post-traumatic or post-surgery related acute mesenteric ischemia
  • lack of assessment in the Emergency Department
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
500 participants (estimated)
Patient registry
No

Groups and cohorts

  • acute mesenteric ischemia

    patients with abdominal pain and acute mesenteric ischemia

  • non-acute mesenteric ischemia

    patients with abdominal pain without mesenteric ischemia

06

What researchers measure

Primary outcomes

  1. In-hospital mortality

    Time frame: 30 days from hospital admission

Secondary outcomes

  1. in-hospital adverse outcome: cardiac arrest, ICU admission, septic shock, major bleeding.

    Time frame: 30 days from hospital admission

07

Study locations

1 of 1 sites recruiting
  • IRCCS San Martino
    Genova, Liguria 16132, Italy
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 5, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02772913
Lead sponsor
University of Genova
Collaborators
University of Bari, University of Siena
Responsible party
Stefano Sartini (Medical doctor, Consultant in Emergency Medicine, University of Genova) — Principal investigator
First posted
May 16, 2016
Start date
Aug 2016
Primary completion
Jun 2017 (estimated)
Completion
Oct 2017 (estimated)
Last update
May 5, 2017

Study contacts

Stefano Sartini, MD
Contact
stefano.sartini@asl3.liguria.it
+39 3402638395
Marcello Pastorelli, Professor
Contact
marcello.pastorelli@unisi.it
+39 0577586660
Vincenzo Savarino, Professor
study chair · University of Genova

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion